2026-2027 | On-Demand Session | Vaping and Tobacco Use: Background, Epidemiology, Regulatory Issues, Safety | September 2026-Vaping and Tobacco Use: Background, Epidemiology, Regulatory Issues, Safety Recording

Video Transcription

Video Summary

Dr. Maureen Strom and Dr. Terrence Sanvictorius present an overview of tobacco, nicotine, and vaping for addiction-medicine clinicians. They trace tobacco’s history, the rise of mass-produced cigarettes, targeted marketing and flavored products, and the development of e-cigarettes and nicotine pouches.<br /><br />Although combustible-cigarette use has declined, vaping became a major source of nicotine use among young people. Vaping products vary widely in nicotine content and may expose users and bystanders to toxic chemicals. Potential harms include cardiovascular and respiratory effects, dependence, and associations with mental-health and other risky behaviors. The presenters also discuss EVALI, largely linked to THC products containing vitamin E acetate, and emphasize that vaping substances beyond nicotine is an emerging concern.<br /><br />The lecture reviews nicotine’s effects on brain receptors and neurotransmitters, its metabolism, withdrawal symptoms, and screening tools such as the Fagerström Test and Heaviness of Smoking Index. Treatment options include motivational interviewing, counseling, quitlines, nicotine-replacement therapy, varenicline, and bupropion. E-cigarettes may help some adults stop smoking, but evidence and long-term outcomes remain uncertain; clinicians should discourage dual use and plan for eventual nicotine cessation. Nicotine pouches may offer harm-reduction potential, but their role and long-term safety require further study.<br /><br />Finally, the speakers describe FDA authorization and tobacco regulations, noting that enforcement gaps and product relabeling allow many unauthorized products to remain available. They urge clinicians to ask about all forms of nicotine use, use evidence-based interventions, and follow patients over time.

Keywords

tobacco

nicotine

vaping

e-cigarettes

nicotine pouches

addiction medicine

smoking cessation

varenicline

bupropion

nicotine replacement therapy

EVALI

Fagerström Test

harm reduction

FDA regulation